Key facts
- This page summarizes Brigid Makes's Form 4/A - Amendment filing for Mind Medicine (MindMed) Inc. (MNMD).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 06 Jun 2022, 16:14.
Brigid Makes - 01 Jun 2022 Form 4/A - Amendment Insider Report for Mind Medicine (MindMed) Inc. (MNMD)
- Reporting relationship
- Director
- Issuer ticker
- MNMD
- Reported as of
- 01 Jun 2022
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 06 Jun 2022, 16:14:09 UTC
- Original report date
- 03 Jun 2022
- Prior SEC filing
- 24 May 2022
- Next SEC filing
- 09 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Barrow, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Brigid Makes filed Form 4/A - Amendment for Mind Medicine (MindMed) Inc. (MNMD) on 06 Jun 2022.
Change
- Previous filing in this sequence was filed on 24 May 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MNMD
transaction
Subordinate Voting Shares
Award
- Transaction value
- $0
- Shares
- +64,656
- Change %
- +69%
- Price
- $0.000000
- Shares after
- 158,706
- Date
- 01 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MNMD
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +100,308
- Change %
- +107%
- Price
- $0.000000
- Shares after
- 194,358
- Date
- 01 Jun 2022
- Ownership
- Direct
- Underlying class
- Subordinate Voting Shares
- Underlying amount
- 100,308
- Exercise price
- $0.6000
- Footnotes
- F2, F3
MNMD
transaction
Derivative
Director's Deferred Share Units
Award
- Transaction value
- Shares
- +361,680
- Change %
- +128%
- Price
- Shares after
- 643,804
- Date
- 01 Jun 2022
- Ownership
- Direct
- Underlying class
- Subordinate Voting Shares
- Underlying amount
- Exercise price
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. The RSUs vest in equal installments over 36 months beginning on June 1, 2022, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
Footnote F2
The option grant has an exercise price of $0.75 Canadian Dollars. This represents the exercise price in United States Dollars.
Footnote F3
1/3rd of the shares underlying the option vest and become exercisable on June 1, 2023; the remaining 2/3rds of the shares underlying the option shall vest in equal installments, vesting at the end of each month thereafter for the succeeding 24 months, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
Footnote F4
Represents Directors' Deferred Share Units ("DDSUs") granted pursuant to the Issuer's Directors' Deferred Share Unit Plan (the "Plan"), effective April 16, 2021. Of these DDSUs, 1/3 vested on June 1, 2022 and the remaining 2/3rds vest in equal installments on June 30, 2022, July 31, 2022, August 31, 2022 and September 30, 2022. The DDSUs are to be settled in cash upon the termination of the Reporting Persons' directorship (each DDSU representing the right to receive the cash equivalent of the fair market value of one Subordinate Voting Share). Pursuant to the Plan, the fair market value of a Subordinate Voting Share is equal to the volume weighted average trading price of a Subordinate Voting Share on the NEO exchange for the five business days immediately preceding the DDSUs vesting date. The DDSUs granted expire no later than 90 days after the Reporting Person's termination date or such other reasonable time as may be determined by the Administrators (defined in the Plan).
SEC remarks
Explanatory Note: This Amendment on Form 4/A is being filed to amend the Form 4 filed on June 3, 2022 solely to update the Expiration Date of the Stock Option in Table 2.